|1.||Penketh, Philip G: 6 articles (11/2011 - 01/2005)|
|2.||Shyam, Krishnamurthy: 6 articles (11/2011 - 01/2005)|
|3.||Sartorelli, Alan C: 6 articles (11/2011 - 01/2005)|
|4.||Baumann, Raymond P: 5 articles (11/2011 - 01/2005)|
|5.||Ishiguro, Kimiko: 4 articles (10/2011 - 11/2005)|
|6.||Wojtasek, Hubert: 3 articles (01/2014 - 06/2008)|
|7.||Sudhandiran, Ganapasam: 2 articles (05/2015 - 03/2014)|
|8.||Prasad, V Ganga: 2 articles (05/2015 - 01/2014)|
|9.||Rao, C Mallikarjuna: 2 articles (05/2015 - 01/2014)|
|10.||Jayashree, B S: 2 articles (05/2015 - 01/2014)|
01/01/1975 - "In a series of 84 various evaluable disseminated cancer patients treated with hydrazine sulfate as a result of a pharmaceutical-sponsored investigational new drug (IND) study, it was found that 59/84 or 70% of the cases improved subjectively and 14/84 or 17% improved objectively. "
12/05/2000 - "To report a case of fulminant hepatorenal failure associated with the use of hydrazine sulfate, an unregulated alternative remedy for cancer marketed on the Internet. "
01/01/1976 - "On the relationship between the activity of acetylation, growth of experimental tumors and efficacy of their suppression by hydrazine sulphate."
03/01/2006 - "Animal studies suggest that hydrazine is a lung carcinogen, but human studies have been rare, rather small, and limited to cancer mortality. "
07/01/1986 - "The most active compound to emerge from this study, 2-[(4-chlorophenyl)sulfonyl]-1-methyl-1-(4-tolylsulfonyl)hydrazine , increased the survival time of tumor-bearing mice by 88%. "
01/01/1955 - "Further studies on the use of streptomycylidene isonicotinyl hydrazine sulfate in the treatment of tuberculosis."
01/01/1952 - "Clinical studies: treatment of tuberculosis with isonicotinic acid hydrazine and its derivatives."
01/01/1952 - "Studies on the activity of hydrazine derivatives of isonicotinic acid in the experimental tuberculosis of mice."
01/01/2014 - "In order to develop a lead antimycobacterium tuberculosis compound, a series of 52, novel pyrrole hydrazine derivatives have been synthesized and screened which target the essential enoyl-ACP reductase. "
01/01/1992 - "Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients."
10/01/1956 - "Further experiences with the clinical use of streptomycylidene isonicotinyl hydrazine sulfate in the therapy of pulmonary tuberculosis."
12/01/1954 - "The use of intermittent (twice weekly) streptomyclidene isonicotyl hydrazine sulphate in the treatment of pulmonary tuberculosis (without oral INH)."
10/01/1954 - "The intermittent use of streptomycylidene isonicotinyl hydrazine sulfate in the therapy of pulmonary tuberculosis."
01/01/1954 - "[Treatment of pulmonary tuberculosis by isonicotinyl isopropyl hydrazine]."
01/01/1953 - "Isonicotinyl hydrazine in the treatment of pulmonary tuberculosis in children; a preliminary report."
|4.||Body Weight (Weight, Body)
03/01/2011 - "Group 2 received 1,2-dimethyl hydrazine (20 mg/kg body weight) subcutaneously once a week for four weeks. "
01/01/1987 - "in Massachusetts, USA, were fasted overnight and given 0, 5, 10, 20, or 40 mg hydrazine per kg body weight by intraperitoneal injection and decapitated 24 hr later. "
02/01/1987 - "These data, which demonstrate an association between 1 month of hydrazine sulfate administration and body weight maintenance in patients with cancer, suggest future clinical trials of hydrazine sulfate are indicated to definitively assess its long-term impact on important clinical outcome parameters in defined cancer populations."
01/01/1976 - "Inhibition of carcinosarcoma Walker-256 by 88% and sarcoma-180 by 36% on treatment with 60 mg/kg body weight of hydrazine sulphate was followed by decreases in the rate of acetylation of 39.4 and 29.4%, respectively. "
03/01/2011 - "Groups 4 to 6 were given a daily oral dose of 50, 100, 200 mg/kg body weight of kaempferol with 1,2-dimethyl hydrazine. "
09/01/2003 - "Currently, the clinical efficacy of cyproheptadine, hydrazine and pentoxyfilline in the treatment of anorexia is uncertain. "
03/01/1995 - "Despite positive pilot trial reports, large randomized studies have been unable to demonstrate a clinically defensible role for either pentoxifylline, cyproheptadine, or hydrazine sulfate for patients with anorexia. "
04/01/1992 - "Efforts are also ongoing to evaluate both anabolic steroids and hydrazine sulfate as drugs for the treatment of patients with cancer anorexia/cachexia. "
11/01/1993 - "Cyproheptadine, hydrazine sulfate, and cannabinoids also are being studied in the management of cancer-induced anorexia, but their role has not yet been clearly established. "
01/01/1992 - "Cyproheptadine, hydrazine sulfate, and cannabinoids also are being studied in the management of cancer-induced anorexia, but their role has not yet been clearly established. "
|1.||Isonicotinic Acids (Isonicotinic Acid)
|2.||Immunoglobulin G (IgG)
|6.||Dihydrostreptomycin Sulfate (Dihydrostreptomycin)
|10.||Adenosine Diphosphate (ADP)
|1.||Drug Therapy (Chemotherapy)
|5.||Nutritional Support (Artificial Feeding)